Deoxyshikonin - CAS 43043-74-9

1. Deoxyshikonin (Arnebin 7) may be a new drug candidate for wound healing and treatment of lymphatic diseases. 2. Deoxyshikonin enhances the ability of human dermal lymphatic microvascular endothelial cells (HMVEC-dLy) to undergo time-dependent in vitro cord formation. 3. Deoxyshikonin and dodecyl gallate show significantly synergic antimicrobial activity with penicillin in vivo and in vitro, and can effectively reduce nasopharyngeal and lung colonization caused by different penicillin-resistant pneumococcal serotypes.

HIF/HIF Prolyl-Hydroxylase, Apoptosis, PI3K, Antibacterial

PI3K/Akt/mTOR signaling, Chromatin/Epigenetic, Microbiology/Virology, Metabolism, Apoptosis

42960

0.9958

C16H16O4

272.3

CC(C)=CCCC1=CC(=O)c2c(O)ccc(O)c2C1=O

-20°C

Ice Packs

Natural Product